
Shifting some of our focus to endometrial cancer. authors.elsevier.com/a/1ickg…

Our lab develops new therapies for ovarian cancer, focusing on quiescent CSC & the immune tumor microenvironment @MageeWomens @UPMCHillmanCC

Shifting some of our focus to endometrial cancer. authors.elsevier.com/a/1ickg…

Former Damon Runyon Clinical Investigator @BuckanovichLab and his team set out to understand why only some ovarian cancer patients respond favorably to immune checkpoint inhibitors, and found that the answer lay in the tumor microenvironment. Learn more: https://t.co/bYHAebRyd9

What if we could prevent the recurrence of #ovariancancer? Through critical research, Magee-Womens Research Institute investigators like Dr. Ronald Buckanovich are giving women with cancer new hope. #OvarianCancerAwarenessMonth Make a gift today: https://t.co/C1qDeWJtQq

A very nice clinical trial from Dr. Lan Coffman


JCI Insight - Phase I trial of ribociclib with platinum chemotherapy in recurrent ovarian cancer insight.jci.org/articles/vie…

I'm supporting National Ovarian Cancer Coalition! do.nr/n0ptze via @DonorDrive

Targeting therapeutic resistance and multinucleate giant cells in CCNE1-amplified HR-proficient ovarian cancer aacrjournals.org/mct/article… A potential new therapeutic approach for women with hard to treat CCNE1 amplified tumors.

authors.elsevier.com/a/1eY3q… Another interesting paper linking metformin therapy and cancer outcomes.

First patients of pioneering CAR T-cell therapy ‘cured of cancer’ theguardian.com/society/2022…

Updated perspective on the Hallmarks of Cancer: New Dimensions | Cancer Discovery #cancer #cancerresearch #oncology #science cancerdiscovery.aacrjournals…

Buckanovich lab is helping to support MWRI's important efforts to facilitate under-represented minorities on a path in science donorbox.org/m3s3

Celebrating the holidays with a multi-national potluck-- Yumm!


Very excited to share our latest paper in @ScienceTM co-led with @BcellBruno on the prevalence of intratumoral Tregs expressing NRP1 and their association with poor outcome in cancer patients. Kudos to my grad student Chris Chuckran who led this study! science.org/doi/10.1126/scit…

.@KellyLeonPSU et al. @airdlab demonstrate that DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. https://t.co/96zVJLPU3N Part of the Year in Cell Biology: 2021 https://t.co/7BZrJIcFnw #CellBio2021